MLND

Millendo Therapeutics (MLND)

Millendo Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MLND

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/21	05:54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/06/21	05:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/06/21	05:47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/06/17	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/05/11	05:25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/05/11	05:22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/05/02	05:16	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/05/02	05:12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/04/28	21:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/04/01	06:08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/02/15	04:57	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MLND	Millendo Therapeutics Inc
2023/02/15	02:11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/12/30	06:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/11/08	23:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/11/08	22:56	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/10/04	21:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/10/04	21:01	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/09/24	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/08/15	21:12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/08/15	21:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/23	05:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLND	Millendo Therapeutics Inc
2022/06/21	21:06	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:MLND	Millendo Therapeutics Inc